tm logo

Monitor this mark

View On USPTO

UNGUARD THERAPEUTICS
Live/Pending
RESPONSE AFTER NON-FINAL ACTION - ENTERED

final action

on 02 Jul 2024

Last Applicant/ Owned by

Argobio

F-75015 Paris

FR

Serial Number

79387308 filed on 01st Dec 2023

Registration Number

N/A

Correspondent Address

Mark L. Weber

Mark L. Weber Renner, Kenner, Greive, Bobak, Taylor &

Suite 400

Akron, OH 44308

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

UNGUARD THERAPEUTICS

Pharmaceutical research and development Pharmaceutical products for the treatment of cancer diseases

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical research and development

First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products

Pharmaceutical products for the treatment of cancer diseases

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79387308

Mark Type

No Service Mark

Attorney Docket Number

No BILQ.T.245

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
17th Oct 2024ASSIGNED TO EXAMINER
02th Jul 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
02th Jul 2024TEAS/EMAIL CORRESPONDENCE ENTERED
02th Jul 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
14th May 2024REFUSAL PROCESSED BY IB
22nd Apr 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22nd Apr 2024REFUSAL PROCESSED BY MPU
03rd Apr 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02th Apr 2024NON-FINAL ACTION WRITTEN
25th Mar 2024ASSIGNED TO EXAMINER